This is a news story, published by ScienceBlog.com, that relates primarily to BH3 news.
For more disease research news, you can click here:
more disease research newsFor more news from ScienceBlog.com, you can click here:
more news from ScienceBlog.comOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
relevant glioblastoma models. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest glioblastoma cells news, glioblastoma news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
glioblastoma modelsScienceBlog.com
•
81% Informative
UCLA scientists have developed a pioneering approach that combines genetic analysis with real-time observation of cancer cell behavior.
Using a technique called BH3 profiling, the team observed how cancer cells respond to treatments designed to trigger cell death, a process that glioblastoma cells typically resist.
This insight led to testing ABBV-155, an experimental drug that targets BCL-XL , a protein that helps cancer cells avoid death.
VR Score
81
Informative language
82
Neutral language
5
Article tone
informal
Language
English
Language complexity
71
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
7
Source diversity
3
Affiliate links
no affiliate links